7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Naloxone
It is an opioid antagonist, which means that it inhibits or reverses the effects of opioid medications. It is mostly used to treat opioid drug overdoses due to its antagonistic properties. Naloxone binds to albumin at a rate of around 45%, although it also strongly interacts with other proteins. In order to stop the effects of opioid drugs, naloxone temporarily inhibits opioid receptors. Because naloxone cannot be used to get high, there is minimal risk that it will be taken without a prescription. There is no evidence that long-term naloxone use can have harmful physiological effects or cause dependence. Users of naloxone do not develop tolerance, and the drug is not known to have contributed to any overdose deaths. This condition primarily affects people in their 20s and 30s. The prodromal phase refers to the time before symptoms appear.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Edie Raether
NeuroShifts and Wings for Wishes Academy, United States
John Michael Weber
Open Door Mission in Houston Texas, United States
Owonaro Peter
Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Sindu Padmanabhan
Bharathiar University, India
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Evaluation of prevalence and pattern of tobacco use in yenagoa city in bayelsa state south of nigeria
Owonaro Peter, Bayelsa State Drug Avuse Addiction Prevention and Rehabilitation Committee (BADAPARC), Nigeria
Title : Engaging learners through gamification, creativity, and human-centered design
Tero Moliis, Versantium, United States
Title : Neuropharmacological and regulatory drivers of tianeptine misuse in the united states: A growing public health concern
Darcy Tocci, NSU College of Pharmacy, United States
Title : Awakening sovereignty within: Healing trauma, releasing codependency, and returning to self-trust
Whitney Walker, Mental Health Therapist/ Podcast Host, United States
Title : You can save a life: Real conversations, real solutions for suicide prevention
frank King, The Mental Health Comedian, LLC, United States